TABLE 1. Monolayer and anchorage independent growth of NSCLC cell lines with knockdown of RAL GTPase.
RALA Knockdown | RALB Knockdown | RALA+B Knockdown | ||||||
---|---|---|---|---|---|---|---|---|
Monolayer Growth | Anchorage Independent Growth | Monolayer Growth | Anchorage Independent Growth | Monolayer Growth | Anchorage Independent Growth | |||
Cell Line | Histology | KRAS | ||||||
H322 | Adenocarcinoma | WT | −52%* | −41.2%* | −33%* | −42.3%* | −46%* | −39%* |
H1703 | Adenocarcinoma | WT | N.S. | N.S. | N.S. | N.S. | N.S. | −52.3%* |
H2228 | Adenocarcinoma | WT | N.S. | N.S. | N.S. | N.S. | N.S. | N.S. |
H292 | Mucoepidermoid | WT | N.S. | No Colony | −23%* | No Colony | N.S. | No Colony |
H4006 | Adenocarcinoma | WT | N.S. | No Colony | N.S. | No Colony | N.S. | No Colony |
Calu3 | Adenocarcinoma | WT | −33%* | No Colony | −36%* | No Colony | −39%* | No Colony |
H2122 | Adenocarcinoma | G12C | −91%* | −97%* | −61%* | −89.2%* | −42%* | −79.6%* |
H358 | Adenocarcinoma | G12C | −24%* | −38%* | N.S. | −27.6%* | −86%* | −83.4%* |
A549 | Adenocarcinoma | G12S | −26%* | −24.5%* | −29%* | N.S. | −27%* | −51.3%* |
H2009 | Adenocarcinoma | G12A | −25%* | −35%* | −19%* | −28.7%* | 28%* | −15.8%* |
H157 | Squamous Cell | G12R | −24%* | N.S. | −19%* | N.S. | N.S. | N.S. |
SW1573 | Alveolar Cell | G12A | N.S. | No Colony | N.S. | No Colony | N.S. | No Colony |
P<0.05 (student's t-test)
(+) indicates increase compared to control
(−) indicates decrease compared to control
“N.S.” is no significant change
“No Colony” indicates cells did not exhibit anchorage independent growth.